Clinical Trial Update: Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the safety of a chemo-immunotherapy combo of ibrutinib and indoximod in pediatric brain tumor patients, including ependymoma, medullo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Ependymoma
• Glioblastoma
• Medulloblastoma

Drugs mentioned

• IMBRUVICA (IBRUTINIB)
• Indoximod (indoximod)

Snippet

Sponsor: Theodore S. Johnson | Conditions: Ependymoma, Medulloblastoma | Phase 1 | Status: RECRUITING